| ²é¿´: 1283 | »Ø¸´: 3 | ||
cj841635ͳæ (ÕýʽдÊÖ)
|
[ÇóÖú]
pmol/injectionÓëÖ®¶ÔÓ¦µÄÖÐÎĵ¥Î»ÊÇʲô
|
|
¿´ÎÄÏ×ÊÇÓöµ½Ò»¸öµ¥Î»pmol/injection£¬ÈÃÎÒºÜÃÔºý£¬ÏëÇë½Ì¸÷λ¸ßÊÖһϣ¬ÓëÖ®¶ÔÓ¦µÄÖÐÎĵ¥Î»ÊÇʲô¡£ÎÄÏ×ÊǹØÓÚµ°°×ÖÊË®½â³É°±»ùËáIDMS¶¨Á¿µÄ¡£ÏÂÃæÊÇÎÄÏ×ÖгöÏÖÕâ¸öµ¥Î»µÄÒ»¾ä»°£º A seven-point calibration curve was prepared for each of the nonlabeled amino acids containing 0, 5, 10, 25, 50, 75, and 100 pmol /injection, respectively. |
» ²ÂÄãϲ»¶
081700£¬311£¬Çóµ÷¼Á
ÒѾÓÐ15È˻ظ´
Ò»Ö¾Ô¸±±¾©»¯¹¤085600 310·ÖÇóµ÷¼Á
ÒѾÓÐ18È˻ظ´
085600²ÄÁÏÓ뻯¹¤301·ÖÇóµ÷¼ÁԺУ
ÒѾÓÐ4È˻ظ´
²ÄÁÏÓ뻯¹¤371Çóµ÷¼Á
ÒѾÓÐ14È˻ظ´
336²ÄÁÏÓ뻯¹¤085600Çóµ÷¼Á
ÒѾÓÐ7È˻ظ´
²ÄÁÏ334Çóµ÷¼Á
ÒѾÓÐ18È˻ظ´
331Çóµ÷¼Á
ÒѾÓÐ8È˻ظ´
332Çóµ÷¼Á
ÒѾÓÐ17È˻ظ´
Ò»Ö¾Ô¸ÄϾ©º½¿Õº½Ìì´óѧ ²ÄÁÏÓ뻯¹¤329·ÖÇóµ÷¼Á
ÒѾÓÐ4È˻ظ´
²ÄÁÏר˶322
ÒѾÓÐ7È˻ظ´
» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:
Ò»¸ö²ÎÓëÈËÁôµÄÓÊÏäºÍµç»°²»Ò»ÖÂËãÎ¥¹æ²»£¿
ÒѾÓÐ9È˻ظ´
·ûºÏ¹úÍâÁôѧµ¥Î»µÄÍâÓïˮƽҪÇóÊÇʲôÒâ˼°¡£¿
ÒѾÓÐ14È˻ظ´
ÇëÎÊnatrue protocols·Òë³ÉÖÐÎÄÃû×ÖÊÇʲô¡£
ÒѾÓÐ6È˻ظ´
²âµç¼«µçÈÝÐÔÄÜʱ£¬¿É²»¿ÉÒÔÇóµ¥Î»Ãæ»ýµçÈÝ£¿
ÒѾÓÐ6È˻ظ´
ÈõÈõµÄÎÊÒ»¾ä£¬¡°·¨¶¨µ¥Î»¡±ÊÇʲôÒâ˼£¿´ýÓöÔõôÑù£¿
ÒѾÓÐ47È˻ظ´
¡¾ÇóÖú¡¿ÈçºÎ½«»¨ÉúËÄÏ©ËáµÄµ¥Î»pmol/L»»ÎªÏàÓ¦µÄpg/mL£¿
ÒѾÓÐ7È˻ظ´
¡¾ÇóÖú¡¿¿¼»·ÆÀÖ¤£¬ËùÔÚµ¥Î»±ØÐëÒªÓл·ÆÀµÄ×ÊÖÊÂð£¿
ÒѾÓÐ18È˻ظ´
¡¾ÇóÖú¡¿½á¹¹»æ»ºóÈçºÎÊäÈ뵥λ·ûºÅºÍÖÐÎÄÎÄ×Ö
ÒѾÓÐ6È˻ظ´
ɽ¶«Ê¯»¯µ¥Î»
ÒѾÓÐ14È˻ظ´
¡¾ÇóÖú¡¿Ê÷Ö¬½»»»º¬Á¿Öе¥Î»mequiv/gÊÇʲôÒâ˼£¿
ÒѾÓÐ6È˻ظ´
¡¾ÇóÖú¡¿DSCÇóìÊËã·åÃæ»ýʱµÄ×ø±êµ¥Î»ÊÇʲô£¿
ÒѾÓÐ24È˻ظ´
ÈçºÎÇóø´Ù·´Ó¦ÖÐ×î´ó·´Ó¦ËÙ¶È£¿µ¥Î»ÊÇʲô£¿
ÒѾÓÐ9È˻ظ´
wddmq
ľ³æ (ÕýʽдÊÖ)
- ACI: 1
- Ó¦Öú: 351 (˶ʿ)
- ¹ó±ö: 0.035
- ½ð±Ò: 2348
- ºì»¨: 6
- Ìû×Ó: 739
- ÔÚÏß: 188.3Сʱ
- ³æºÅ: 1339722
- ×¢²á: 2011-07-07
- רҵ: Ò©Îï·ÖÎö

2Â¥2012-03-23 13:03:01
![]() ![]() |
3Â¥2012-03-24 08:09:07
cj841635
ͳæ (ÕýʽдÊÖ)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 697.1
- ºì»¨: 1
- Ìû×Ó: 435
- ÔÚÏß: 52.4Сʱ
- ³æºÅ: 679280
- ×¢²á: 2008-12-22
- רҵ: É«Æ×·ÖÎö
4Â¥2012-03-25 11:56:50














»Ø¸´´ËÂ¥
